ResourceDrug Discovery & Development
Mastering multi-specific antibody production for next-gen drug discovery
31 Oct 2025The ongoing AI revolution opens up a new era of antibody design, with a focus on bi-specific antibodies. Gain insight into how artificial intelligence (AI) is assisting next-generation drug discovery in the production of multispecific antibodies.
Resource details:
- Resource type: Scientific poster
- Page count: 1
- Read time: 2 mins
Related products
Request Quote for All Products
TurboCHO™ Bi-specific Antibody Expression
GenScript70+ different formats of bsAb produced; 5,000+ bsAb projects delivered; 6+ optimized processes provided
TurboCHO™ Antibody Expression Service
GenScript5 Business Days from Gene to Antibody – Say Goodbye To Waiting
Links
Tags
AntibodiesAntibodies are used in techniques such as confocal and fluorescence microscopy, flow cytometry, ELISA, ELISPOT, immunohistochemistry, western blotting and immunopreciptation. Select specific antigen reactivity, high specific affinity, low non-specific binding, monoclonal or polyclonal, primary or secondary antibodies and associated conjugates such as an enzyme or dye for visualization.AIBiotherapeuticsBiotherapeutics are proteins and other compounds (such as nucleic acids) produced by living organisms that have uses as therapeutics or in in vivo diagnostics. The most well-known example of a biotherapeutic product, and the first to be approved for therapeutic use, was recombinant human insulin.CHOEngineered AntibodiesEngineered antibodies are modified to enhance specificity, stability, and functionality for therapeutic and diagnostic applications. These antibodies are central to immunotherapy and biomarker detection. Compare engineered antibody solutions in our directory to find top products and reviews.